BioCurex announced that its wholly owned subsidiary, OncoPet Diagnostics, has entered into a distribution agreement for its companion animal OncoPet RECAF cancer detection test with United Lee Corporation (UL Corp), based in Seoul, Korea. The agreement is exclusive for the distribution of companion animal RECAF tests throughout Korea.
Since 1994, UL Corp has continued to be a leading importer and distributor of medical devices and equipment into Korea from manufacturers around the globe. UL Corp is widely recognized as a leading distributor for introducing new technologies and concepts into the Korean healthcare market. In addition, in 2002, UL Corp established a hospital consulting business in Hanoi, Vietnam.
"By signing an agreement with UL Corp, we are continuing to extend our distribution area in Asia and look forward to offering our RECAF test, which will now provide veterinarians with the first test ever to diagnose and treat cancer in companion animals at an affordable cost," said OncoPet Diagnostics President and BioCurex CEO Dr. Ricardo Moro-Vidal.
"Both in Taiwan and in Korea, the tests will be performed at local laboratories thus ensuring affordable and timely service."
Source: BioCurex, Inc.